Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer research, Prostate cancer, Androgen receptor, Enzalutamide, Triple-negative breast cancer, and Biology.
Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma
S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling
KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
Transporting Cells in Semi-Solid Gel Condition and at Ambient Temperature
Estrogen-Related Receptor Alpha Confers Methotrexate Resistance via Attenuation of Reactive Oxygen Species Production and P53 Mediated Apoptosis in Osteosarcoma Cells
MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth
Histone Methyltransferase NSD2/MMSET Mediates Constitutive NF-κB Signaling for Cancer Cell Proliferation, Survival, and Tumor Growth via a Feed-Forward Loop